Methylxanthines: toxicity to humans. 1. Theophylline.

While there are several comprehensive reviews on the toxic effects of theophylline, caffeine and theobromine in animals, data on the toxicity of these methylxanthines in humans have not been extensively reviewed in one document. This question will be addressed in a series of three papers. This paper provides an overview of the human toxicity of theophylline. Only pertinent and recent information on theophylline toxicity is summarized. In addition, some information regarding the use and benefits of theophylline, the mechanism of its effects and factors that affect variability in its clearance and half-life is also provided. Some problems in the analytical methodology of theophylline, problems that may be responsible for the controversy in the reported dose-response effects, are critically reviewed.

[1]  E. Singer,et al.  Seizures due to theophylline overdose. , 1985, Chest.

[2]  C. Lam,et al.  Pitfalls in the interpretation of serum theophylline levels. , 1982, American journal of diseases of children.

[3]  N. Buchanan,et al.  Theophylline metabolism in preterm neonates during the first weeks of life. , 1984, Developmental pharmacology and therapeutics.

[4]  P. Auld,et al.  Oxygen consumption in apneic premature infants after low‐dose theophylline , 1980, Clinical pharmacology and therapeutics.

[5]  R. Rogers,et al.  The pendulum swings again. Toward a rational use of theophylline. , 1985, Chest.

[6]  T. J. Haley,et al.  Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults. , 1983, Drug metabolism reviews.

[7]  S. Mcgeady,et al.  The relationship of cerebrospinal fluid and plasma theophylline concentrations in children and adolescents taking theophylline. , 1985, The Journal of allergy and clinical immunology.

[8]  S. Penner,et al.  Metabolic abnormalities associated with intentional theophylline overdose. , 1984, Annals of internal medicine.

[9]  W. Wargin,et al.  Separation and quantitation of theophylline and paraxanthine by reversed-phase liquid chromatography. , 1980, Clinical chemistry.

[10]  P. Conlon,et al.  Comparison of Two Sustained‐Release Theophylline Preparations in Adult Patients With Obstructive Airways Disease , 1985, Journal of clinical pharmacology.

[11]  A. Staib,et al.  Pharmacokinetics and metabolism of theophylline in patients with liver diseases. , 1980, International journal of clinical pharmacology, therapy, and toxicology.

[12]  I. Tebbutt,et al.  Caffeine, theophylline and theobromine in pregnancy. , 1984, Biological research in pregnancy and perinatology.

[13]  R. Royer,et al.  Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. , 1979, The Journal of pediatrics.

[14]  R. Baughman,et al.  Prolonged toxicity following massive ingestion of sustained-release theophylline preparation. , 1985, Chest.

[15]  Gary Milavetz,et al.  MULTICENTRE EVALUATION OF DISPOSABLE VISUAL MEASURING DEVICE TO ASSAY THEOPHYLLINE FROM CAPILLARY BLOOD SAMPLE , 1986, The Lancet.

[16]  T. Guarnieri,et al.  MULTIFOCAL ATRIAL TACHYCARDIA: A TOXIC EFFECT OF THEOPHYLLINE , 1985, The Lancet.

[17]  K. Renton,et al.  Depression of theophylline elimination by erythromycin , 1981, Clinical pharmacology and therapeutics.

[18]  S. Taller.  Oral theophylline intoxication. , 1985, Archives of internal medicine.

[19]  L. Hendeles,et al.  Improved efficacy and safety of theophylline in the control of airways hyperreactivity. , 1982, Annals of allergy.

[20]  M. E. Gardner,et al.  Ranitidine and theophylline. , 1985, Annals of internal medicine.

[21]  J. Williams,et al.  Effects of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats. , 1979, Biochemical pharmacology.

[22]  R. Ogilvie.  Clinical Pharmacokinetics of Theophylline , 1978, Clinical pharmacokinetics.

[23]  B. Kimelblatt,et al.  Cimetidine-theophylline interaction: report of four patients. , 1982, Annals of allergy.

[24]  P. Kroboth,et al.  Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion. , 1984, The American journal of medicine.

[25]  K. Opheim,et al.  Increase in apparent theophylline concentration in the serum of two patients as measured by some immunoassay methods (caused by 1,3-dimethyluric acid?) , 1983, Clinical chemistry.

[26]  A. Pradalier,et al.  Pharmacokinetics of theophylline in night-workers. , 1982, British journal of clinical pharmacology.

[27]  E. Labovitz,et al.  Placental theophylline transfer in pregnant asthmatics. , 1982, JAMA.

[28]  L. Heilbronn,et al.  Oral contraceptive steroids impair the elimination of theophylline. , 1983, The Journal of laboratory and clinical medicine.

[29]  R. Matthay.  Effects of theophylline on cardiovascular performance in chronic obstructive pulmonary disease. , 1985, Chest.

[30]  K. Tserng.  Gas chromatographic-mass spectrometric quantitation of theophylline and its metabolites in biological fluids. , 1983, Journal of pharmaceutical sciences.

[31]  S. Szefler,et al.  Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children. , 1985, The Journal of pediatrics.

[32]  R. Roberts,et al.  Use of hemoperfusion for treatment of theophylline intoxication. , 1983, The American journal of medicine.

[33]  N. Benowitz,et al.  Benefit of hemoperfusion in acute theophylline intoxication. , 1984, Journal of toxicology. Clinical toxicology.

[34]  W. Pierson,et al.  Altered theophylline clearance during an influenza B outbreak. , 1982, Pediatrics.

[35]  K. Whyte,et al.  TOXICITY OF SALBUTAMOL AND THEOPHYLLINE TOGETHER , 1983, The Lancet.

[36]  J. Henry,et al.  PROPRANOLOL ADMINISTRATION IN THEOPHYLLINE OVERDOSE , 1985, The Lancet.

[37]  H. Cornish,et al.  A study of the metabolism of theobromine, theophylline, and caffeine in man. , 1957, The Journal of biological chemistry.

[38]  D. Greenblatt,et al.  Clinical toxocity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program. , 1978, Chest.

[39]  J. Dasta,et al.  Placental transfer of theophylline: two case reports. , 1979, Pediatrics.

[40]  R. Ogilvie,et al.  Theophylline disposition in patients with hepatic cirrhosis. , 1977, The New England journal of medicine.

[41]  D. Nicholson.  Clinical experience with theophylline. , 1976, JAMA.

[42]  S. Mckenzie,et al.  Clinical applications of serum theophylline measurement by high pressure liquid chromatography. , 1978, Archives of Disease in Childhood.

[43]  F. Lovejoy,et al.  Acute pediatric theophylline overdose: a summary of 28 cases. , 1983, The Journal of pediatrics.

[44]  M. Oellerich,et al.  Nocturnal asthma: effect of a once per evening dose of sustained release theophylline. , 1985, European journal of respiratory diseases.

[45]  H. Modanlou,et al.  Theophylline toxicity in a preterm infant: selected clinical aspects. , 1985, Pediatric pharmacology.

[46]  L. Hendeles,et al.  Theophylline use: an overview. , 1985, The Journal of allergy and clinical immunology.

[47]  A. Hodgkinson,et al.  Single-reagent polarization fluoroimmunoassay for theophylline in serum. , 1986, Therapeutic drug monitoring.

[48]  R. Wiggins,et al.  A possible effect of the methylxanthines caffeine, theophylline and aminophylline on postnatal myelination of the rat brain , 1981, Brain Research.

[49]  T. Sullivan,et al.  Intravenous administration of aminophylline in asthmatic children taking theophylline orally. , 1980, The Journal of pediatrics.

[50]  N. Herschkowitz,et al.  Theophylline Reduces the Activity of Cerebroside-Sulfotransferase, a Key Enzyme in Myelination, in Cell Cultures from Newborn Mouse Brain , 1980, Pediatric Research.

[51]  R. Baselt,et al.  Markedly prolonged theophylline half-life in liver failure. , 1982, Journal of analytical toxicology.

[52]  W. G. Parkin,et al.  Charcoal hemoperfusion treatment of severe theophylline toxicity. , 1985, Australian and New Zealand journal of medicine.

[53]  M. Noetzel.  Theophylline Neurotoxicity Resulting in Significant Unilateral Brain‐damage , 1985, Developmental medicine and child neurology.

[54]  A. Motulsky,et al.  Theophylline metabolism: Variation and genetics , 1984, Clinical pharmacology and therapeutics.

[55]  B. Zarowitz,et al.  Alterations in theophylline protein binding in acutely ill patients with COPD. , 1985, Chest.

[56]  W. Hurst,et al.  Analytical methods for quantitation of methylxanthines. , 1984, Progress in clinical and biological research.

[57]  S. Pedersen,et al.  Influence of food on the absorption of theophylline from a sustained release formulation (Somophyllin ® ) , 1985, Clinical allergy.

[58]  R. W. Jenny,et al.  Two types of error found with the Seralyzer ARIS assay of theophylline. , 1986, Clinical Chemistry.

[59]  P. Barnes,et al.  Rapid estimation of plasma theophylline concentrations. , 1985, British medical journal.

[60]  R. Seidelin,et al.  Indigenous Amoebiasis: A Recent Outbreak in England , 1952, British medical journal.

[61]  R. Cowan,et al.  RHABDOMYOLYSIS AND ACUTE RENAL FAILURE AFTER THEOPHYLLINE OVERDOSE , 1985, The Lancet.

[62]  S. Szefler,et al.  Theophylline absorption in young asthmatic children receiving sustained-release formulations. , 1985, The Journal of pediatrics.

[63]  R. Ogilvie,et al.  Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics , 1972, Clinical pharmacology and therapeutics.

[64]  B. Stavric,et al.  HPLC Separation of Theophylline, Paraxanthine, Theobromine, Caffeine and Other Caffeine Metabolites in Biological Fluids , 1983 .

[65]  R. Dahlqvist,et al.  Theophylline--clinical pharmacokinetics and therapeutic drug monitoring. , 1984, European journal of respiratory diseases. Supplement.

[66]  J. Volpe,et al.  Reduction of Cholesterol Synthesis by Methylxanthines in Cultured Glial Cells , 1979, Pediatric Research.

[67]  C. van der Meer,et al.  Determination of caffeine in serum by straight-phase high-performance liquid chromatography. , 1980, Journal of chromatography.

[68]  R. Labow.  Effects of caffeine being studied for treatment of apnea in newborns. , 1983, Canadian Medical Association journal.

[69]  P. Kramer,et al.  Improved micro-method for the high-performance liquid chromatographic determination of caffeine and paraxanthine in biological fluids. , 1984, Journal of chromatography.

[70]  A. Staib,et al.  Determination of theophylline in serum by non-isotopic immunoassays (EMIT, SLFIA, NIIA) and HPLC — A comparative study , 1982 .

[71]  C. Ou,et al.  Concurrent measurement of theophylline and caffeine in neonates by an interference-free liquid-chromatographic method. , 1983, Clinical chemistry.

[72]  C. Bate,et al.  Fatal overdose of theophylline simulating acute pancreatitis. , 1982, British medical journal.

[73]  L. Hendeles,et al.  Current concepts. Slow-release theophylline rationale and basis for product selection. , 1983, The New England journal of medicine.

[74]  J. Grygiel,et al.  Effect of age on patterns of theophylline metabolism , 1980, Clinical pharmacology and therapeutics.

[75]  P. Thompson,et al.  The effect of diet upon serum concentrations of theophylline. , 1983, British journal of clinical pharmacology.

[76]  J. Jonkman,et al.  Interference in the proposed selected method for determination of theophylline by liquid chromatography. , 1982, Clinical chemistry.

[77]  H. Kubo,et al.  Preparation of anti-theophylline antiserum and determination of theophylline in patient blood by radioimmunoassay method. , 1979, Chemical & pharmaceutical bulletin.

[78]  S. Pedersen,et al.  Erratic absorption of a slow-release theophylline sprinkle product. , 1984, Pediatrics.

[79]  C. Feldman,et al.  Theophylline blood levels as a guide to intravenous therapy in children. , 1982, American journal of diseases of children.

[80]  S. Spector.  Advantages and disadvantages of 24-hour theophylline. , 1985, The Journal of allergy and clinical immunology.

[81]  J. Phillis,et al.  The role of adenosine and its nucleotides in central synaptic transmission , 1981, Progress in Neurobiology.

[82]  P. Mitznegg,et al.  The influence of low and high doses of theophylline on spontaneous motility and cyclic 3',5' AMP content in isolated rat uterus. , 1974, Life sciences.

[83]  S. Pedersen,et al.  Serum Concentrations of Theophylline in Children Treated with Two Daily Doses of a Sustained‐Release Theophylline Preparation , 1981, Allergy.

[84]  E. Sugita,et al.  Kinetics of intravenous theophylline , 1977, Clinical pharmacology and therapeutics.

[85]  D. Berry,et al.  Theophylline poisoning in adults. , 1979, British medical journal.

[86]  R. Walstad,et al.  The influence of sustained release theophylline therapy on free fatty acids in serum. , 2009, Acta pharmacologica et toxicologica.

[87]  A. Isles,et al.  Pharmacokinetics of a sustained-release theophylline preparation in infants and preschool children with asthma. , 1985, The Journal of allergy and clinical immunology.

[88]  I Magnussen,et al.  THE EFFECT OF INTRAARTERIAL ADMINISTERED AMINOPHYLLINE ON CEREBRAL HEMODYNAMICS IN MAN , 1977, Acta neurologica Scandinavica.

[89]  D. Morgan,et al.  Influence of chronic dosing on theophylline clearance. , 1985, British journal of clinical pharmacology.

[90]  J. Lima,et al.  Liquid chromatographic determination of caffeine in biologic fluids. , 1982, Journal of chromatography.

[91]  S. Riegelman,et al.  Metabolism of theophylline to caffeine in adults. , 1981, Research communications in chemical pathology and pharmacology.

[92]  H. Bada,et al.  Interconversion of theophylline and caffeine in newborn infants. , 1979, The Journal of pediatrics.

[93]  M. Bonati,et al.  Theophylline distribution in the premature neonate. , 1981, Developmental pharmacology and therapeutics.

[94]  L. Paalzow,et al.  Pharmacokinetics and dose regimen of oral theophylline in children. , 2009, Acta pharmacologica et toxicologica.

[95]  W. Parsons,et al.  Delayed elimination of caffeine by women in the last 2 weeks of pregnancy. , 1982, Canadian Medical Association journal.

[96]  A. Manoguerra,et al.  Theophylline toxicity and the beta-adrenergic system. , 1985, Annals of internal medicine.

[97]  D. H. Wells,et al.  Survival after massive aminophylline overdose in a premature infant. , 1979, Pediatrics.

[98]  G. Levy,et al.  Pharmacokinetics of theophylline in children with asthma. , 1976, Pediatrics.

[99]  B B Fredholm,et al.  On the mechanism of action of theophylline and caffeine. , 2009, Acta medica Scandinavica.

[100]  R. Senior,et al.  Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. , 1976, JAMA.

[101]  H. Nagasawa,et al.  Decreased theophylline half-life in cigarette smokers. , 1975, Life sciences.

[102]  W. Pierson,et al.  LEARNING AND BEHAVIOUR PROBLEMS ASSOCIATED WITH THEOPHYLLINE THERAPY , 1984, The Lancet.

[103]  N. Benowitz,et al.  Theophylline overdose: acute single ingestion versus chronic repeated overmedication. , 1985, The American journal of emergency medicine.

[104]  G. Sierra-marcuňo,et al.  High Performance Liquid Chromatographic Procedure for the Simultaneous Determination of Theophylline, Caffeine, and Phenobarbital in Neonates , 1985, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[105]  J. Brazier,et al.  Plasma xanthine levels in low birthweight infants treated or not treated with theophylline. , 1979, Archives of disease in childhood.

[106]  R. V. van Kesteren,et al.  Massive Theophylline Intoxication: Effects of Charcoal Haemoperfusion on Plasma and Erythrocyte Theophylline Concentrations , 1985, Human toxicology.

[107]  T. Chang,et al.  Albumin-collodion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year-old patient. , 1980, Pediatrics.

[108]  W. Jusko,et al.  Effects of tobacco smoking and oral contraceptive use on theophylline disposition. , 1983, British journal of clinical pharmacology.

[109]  J. Schwartz,et al.  Theophylline kinetics: dose dependency and single sample prediction of clearance. , 1985, Pharmacology.

[110]  S. Riegelman,et al.  Improved high-performance liquid chromatographic assay for theophylline in plasma and saliva in the presence of caffeine and its metabolites and comparisons with three other assays. , 1982, Journal of chromatography.

[111]  T. Nakada,et al.  Theophylline-induced seizures: clinical and pathophysiologic aspects. , 1983, The Western journal of medicine.

[112]  E. Moerman,et al.  Determination of plasma theophylline by straight-phase high-performance liquid chromatography: elimination of interfering caffeine metabolites. , 1981, Journal of chromatography.

[113]  R. P. Maickel,et al.  Physicochemical factors in maternal-fetal distribution of drugs. , 1973, Toxicology and applied pharmacology.

[114]  L. Hendeles,et al.  Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children. , 1980, The Journal of pediatrics.

[115]  R. Hall,et al.  Decreased elimination of theophylline after influenza vaccination. , 1980, Canadian Medical Association journal.

[116]  L. Hendeles,et al.  Guide to oral theophylline therapy for the treatment of chronic asthma. , 1978, American journal of diseases of children.

[117]  C. Sessler,et al.  Treatment of theophylline toxicity with oral activated charcoal. , 1985, Chest.

[118]  C. Lacroix,et al.  [Theophylline-caffeine interaction in bronchial disease patients with cardiac and hepatic failure]. , 1985, Presse medicale.

[119]  R. Ogilvie,et al.  Theophylline kinetics in acute pulmonary edema , 1977, Clinical pharmacology and therapeutics.

[120]  S. Sahney,et al.  Hemoperfusion in theophylline neurotoxicity. , 1983, Pediatrics.

[121]  J. Jenne,et al.  Pharmacokinetics of theophylline; Application to adjustment of the clinical dose of aminophylline , 1972, Clinical pharmacology and therapeutics.

[122]  R. Woody,et al.  A Second Case of Infantile Intracranial Hemorrhage and Severe Neurological Sequelae following Theophylline Overdose , 1986, Developmental medicine and child neurology.

[123]  R. Lockey,et al.  Theophylline kinetics in a geriatric group , 1983, Clinical pharmacology and therapeutics.

[124]  M. T. Stevens,et al.  Evaluation of the Effect of Food on the Absorption of Sustained‐Release Theophylline and Comparison of Two Methods for Serum Theophylline Analysis , 1986, Journal of clinical pharmacology.

[125]  S. Snyder,et al.  Adenosine as a Mediator of the Behavioral Effects of Xanthines , 1984 .

[126]  L. Hendeles,et al.  Avoidance of Adverse Effects during Chronic Therapy with Theophylline , 1980, European journal of respiratory diseases. Supplement.

[127]  M. Baker,et al.  Theophylline toxicity in children. , 1986, The Journal of pediatrics.

[128]  L Hendeles,et al.  Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity. , 1985, Chest.

[129]  J. Kaplanski,et al.  Effect of exercise and environmental heat on theophylline kinetics. , 1984, Respiration; international review of thoracic diseases.

[130]  R. Manfredi,et al.  Inhibition of theophylline metabolism by long‐term allopurinol administration , 1981, Clinical pharmacology and therapeutics.

[131]  A. Woodcock,et al.  THEOPHYLLINE PRESCRIBING, SERUM CONCENTRATIONS, AND TOXICITY , 1983, The Lancet.

[132]  M. Weinberger.  Theophylline for treatment of asthma. , 1978, The Journal of pediatrics.

[133]  R. Warburton,et al.  Risk of giving intravenous aminophylline to acutely ill patients receiving maintenance treatment with theophylline. , 1984, British medical journal.

[134]  J J Schentag,et al.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. , 1979, Journal of pharmaceutical sciences.

[135]  L. Hendeles,et al.  Update on the pharmacodynamics and pharmacokinetics of theophylline. , 1985, Chest.

[136]  E. Horn,et al.  THEOPHYLLINE POISONING AND RHABDOMYOLYSIS , 1985, The Lancet.

[137]  G. Milavetz,et al.  Stability of theophylline elimination rate , 1987, Clinical pharmacology and therapy.

[138]  N. Chu,et al.  Focal seizures and aminophylline , 1975, Neurology.

[139]  R. Vestal,et al.  Cigarette smoking and theophylline metabolism: Effects of cimetidine , 1985, Clinical pharmacology and therapeutics.

[140]  S. Godfrey,et al.  Clinical, physiologic, and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma. , 1985, The Journal of allergy and clinical immunology.

[141]  S. Kety,et al.  The effects of intravenously administered aminophylline on cerebral circulation and metabolism in man. , 1950, The Journal of clinical investigation.

[142]  T. Yeh,et al.  TRANSPLACENTAL AMINOPHYLLINE TOXICITY IN A NEONATE , 1977, The Lancet.

[143]  M. Weil,et al.  Cardiac Arrest in the Critically Ill: I. A Study of Predisposing Causes in 132 Patients , 1971, Circulation.

[144]  R. Matthay,et al.  Theophylline-induced seizures in adults. Correlation with serum concentrations. , 1975, Annals of internal medicine.

[145]  A. Breckenridge,et al.  Lack of effect of highly purified subunit influenza vaccination on theophylline metabolism. , 1985, British journal of clinical pharmacology.

[146]  N. Finer,et al.  An evaluation of theophylline for idiopathic apnea of infancy. , 1984, Developmental pharmacology and therapeutics.

[147]  L. Hendeles,et al.  Theophylline product and dosing interval selection for chronic asthma. , 1985, The Journal of allergy and clinical immunology.

[148]  R. Slavin,et al.  A fatal case of theophylline intoxication. , 1983, Archives of internal medicine.

[149]  S. Godfrey,et al.  COMPARISON OF CROMOGLYCATE (CROMOLYN) AND THEOPHYLLINE IN CONTROLLING SYMPTOMS OF CHRONIC ASTHMA A Collaborative Study , 1977, The Lancet.

[150]  R. Blouin,et al.  The Effect of Acute and Chronic Renal Failure on Theophylline Clearance , 1982, Journal of clinical pharmacology.

[151]  M. Jensen,et al.  Is theophylline-induced seizures in man caused by inhibition of cerebral 5'-nucleotidase activity? , 2009, Acta pharmacologica et toxicologica.

[152]  R. Lindberg,et al.  Determination of theophylline in serum with the Seralyzer Aris reagent strip test evaluated. , 1985, Clinical chemistry.

[153]  K. Simons,et al.  Theophylline toxicity in term infants. , 1980, American journal of diseases of children.

[154]  J L Brazier,et al.  Pharmacokinetics of caffeine during and after pregnancy. , 1983, Developmental pharmacology and therapeutics.

[155]  J. Aitchison,et al.  Treatment of theophylline neurotoxicity with resin hemoperfusion. , 1978, Annals of internal medicine.

[156]  E. Renner,et al.  High-performance liquid chromatographic determination of dimethylxanthine metabolites of caffeine in human plasma. , 1985, Journal of chromatography.

[157]  L. Hendeles,et al.  FOOD-INDUCED DOSE DUMPING OF ONCE-A-DAY THEOPHYLLINE , 1984, The Lancet.

[158]  S. Jackson,et al.  Is circadian variation in theophylline trough serum concentrations determined by time of dosing? , 1984, British journal of clinical pharmacology.

[159]  J. Caldwell,et al.  Influence of methylxanthine‐containing foods on theophylline metabolism and kinetics , 1979, Clinical pharmacology and therapeutics.

[160]  J. May,et al.  The effect of whole virus influenza vaccination on theophylline pharmacokinetics. , 1988, The American review of respiratory disease.

[161]  G. Levy,et al.  Renal Clearance of Theophylline in Man , 1976, Journal of clinical pharmacology.

[162]  A. Dutt,et al.  Theophylline kinetics in chronic obstructive airway disease in the elderly , 1985, Clinical pharmacology and therapeutics.

[163]  R. Wurtman,et al.  Caffeine and the Cardiovascular Effects of Physiological Levels of Adenosine , 1984 .

[164]  M. Weinberger,et al.  Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children. , 1974, The Journal of pediatrics.

[165]  S. Riegelman,et al.  Nonlinear theophylline elimination , 1982, Clinical pharmacology and therapeutics.

[166]  M. R. Mickey,et al.  Behavior abnormalities and poor school performance due to oral theophylline use. , 1986, Pediatrics.

[167]  S. Sved,et al.  The human metabolism of caffeine to theophylline. , 1976, Research communications in chemical pathology and pharmacology.

[168]  M. Weinberger,et al.  Dose-dependent kinetics of theophylline disposition in asthmatic children. , 1977, The Journal of pediatrics.

[169]  C. Criée,et al.  RHABDOMYOLYSIS AFTER THEOPHYLLINE OVERDOSE , 1985, The Lancet.

[170]  Sublett Jl,et al.  Acute theophylline intoxication. Biphasic first order elimination kinetics in a child. , 1978 .

[171]  R. Hartley,et al.  Simultaneous determination of caffeine and its N-demethylated metabolites in umbilical cord plasma using high-performance liquid chromatography. , 1984, Journal of chromatography.

[172]  M. Bethenod,et al.  Metabolism of theophylline to caffeine in premature newborn infants. , 1979, The Journal of pediatrics.

[173]  G. Spiller.  The Methylxanthine beverages and foods : chemistry, consumption, and health effects , 1984 .

[174]  R. Braithwaite,et al.  THEOPHYLLINE POISONING , 1983, The Lancet.

[175]  R. Hartley,et al.  Improved high-performance liquid chromatographic method for the simultaneous determination of caffeine and its N-demethylated metabolites in plasma using solid-phase extraction. , 1985, Journal of chromatography.

[176]  R. Levy,et al.  Unsuspected Caffeine Toxicity Complicating Theophylline Therapy , 1984, Human toxicology.

[177]  D. Rice,et al.  Elimination of chronically consumed caffeine in the pregnant monkey (Macaca fascicularis). , 1986, The Journal of pharmacology and experimental therapeutics.